Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials June 16, 2024
Study Shows AI-Powered Drug Discovery Has Near Perfect Success Rate in Phase I Clinical Trials June 12, 2024
Unlearn Raises $50M Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology February 13, 2024
Enveda Biosciences Announces $55M in New Funding to Accelerate Platform and Advance Multiple Candidates to Clinical Trials June 16, 2024
Study Shows AI-Powered Drug Discovery Has Near Perfect Success Rate in Phase I Clinical Trials June 12, 2024
Unlearn Raises $50M Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology February 13, 2024